Viewers in Africa, Asia, and Australia will be able to see the blood moon in the sky—but those in the Americas will have to settle for a live feed this time around.

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

ECLIPSE 2 is one of three trials in Vir Biotechnology’s registrational ECLIPSE program for CHD, which was initiated in March 2025 .

SQL had a somewhat unusual journey in the TIOBE Index. In 2004, due to debates about whether SQL counted as a programming language at all, Jansen removed it from the index.

Building on Northrop's Antares and Firefly's Alpha heritage, Eclipse combines proven avionics with a 5.4-meter payload fairing, carbon-composite structures, and scaled-up propulsion.

Get insights into Vir Biotechnology's Q1 2025 earnings call, including ECLIPSE Phase III trial progress, oncology updates, and financial highlights.

ECLIPSE is a Phase 3 registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta.